NIH (National Institutes of Health) accounted the event about the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Intoduction- NIH (National Institutes of Health) accounted the event about the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership program develop a cascade research
approach for the development and promising treatments and vaccine In prioritizing manner on 17 April,2020.

Involving in this Coordinated research, involving ACTIV and NIH working with the sibling agencies in Health and Human Services department by the FNIH ( Foundation for the National Institutes of Health).

These all organization working such as Biomedical Advanced Research and Development Authority (BARDA), Centers for Disease Control and Prevention (CDC), and the U.S. Food and Drug Administration (FDA);
other government agencies including the Department of Defense (DOD) and Department of Veterans Affairs (VA); Countermeasures Acceleration Group (formerly known as Operation Warp Speed); the European
Medicines Agency (EMA); and representatives from academia, philanthropic organizations, and numerous biopharmaceutical companies.
 

Challenges- With limited resources we need a good cascade or coordinated
processes to try to make a best preclinical trails and use the biomedical
research resources.

Opportunity- five fast-track focus areas pursuing by NIH along with the ACTIV
initiative
senior scientists representing such as government, industry, non-profit,
philanthropic, and academic organizations.

The groups of preclinical working on this - make a establishing proccess for harmonizing

▪Sharing methods
▪Evaluation animals model
▪Validate animal model
▪Increasing comparison strategies
▪Informative assays
▪Generate a process on vaccines